Avalo Therapeutics (AVTX) Return on Assets [ROA] (2015 - 2026)
Avalo Therapeutics (AVTX) recorded Return on Assets [ROA] of -33.97% in Q2 2026, up 0.89 percentage points from -34.87% a year earlier and up 44.37 percentage points from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Avalo Therapeutics reported Return on Assets [ROA] of -58.58%, down 17.67 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of +100.44 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -40.91% in FY2024 (+75.14 pp), -116.06% in FY2023 (-42.70 pp), -73.35% in FY2022 (+62.77 pp) and -136.12% in FY2021 (+22.90 pp).
- The Q2 2026 figure is the highest quarterly Return on Assets [ROA] since Q1 2025.
- On a year-over-year basis, Return on Assets [ROA] rose in four of the last eight quarters, with an average year-over-year change of +27.72 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 247.94 percentage points in Q1 2025, against a drop of 128.82 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -78.34% (Q1 2026), -64.80% (Q4 2025) and -79.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - | -33.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.97% |
| Mar 31, 2026 | -78.34% |
| Dec 31, 2025 | -64.80% |
| Sep 30, 2025 | -79.37% |
| Jun 30, 2025 | -34.87% |
| Mar 31, 2025 | 50.48% |
| Dec 31, 2024 | -28.19% |
| Sep 30, 2024 | -7.70% |
| Jun 30, 2024 | -31.22% |
| Mar 31, 2024 | -197.45% |
| Dec 31, 2023 | -125.52% |
| Sep 30, 2023 | -124.06% |
| Jun 30, 2023 | -81.92% |
| Mar 31, 2023 | -84.95% |
| Dec 31, 2022 | -119.17% |
| Sep 30, 2022 | -148.44% |
| Jun 30, 2022 | -152.20% |
| Mar 31, 2022 | -106.60% |
| Dec 31, 2021 | -96.12% |
| Sep 30, 2021 | -101.38% |
API Access
Avalo Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();